You just read:

Akrevia Therapeutics Licenses Exclusive Rights from City of Hope to Expand Development Pipeline of Potent, Tumor Targeted Immunotherapies

News provided by

Akrevia Therapeutics; City of Hope

Mar 26, 2019, 07:30 ET